210 related articles for article (PubMed ID: 22820861)
1. Antileukemic activity of combined epigenetic agents, DNMT inhibitors zebularine and RG108 with HDAC inhibitors, against promyelocytic leukemia HL-60 cells.
Savickiene J; Treigyte G; Borutinskaite VV; Navakauskiene R
Cell Mol Biol Lett; 2012 Dec; 17(4):501-25. PubMed ID: 22820861
[TBL] [Abstract][Full Text] [Related]
2. DNA methyltransferase inhibitor RG108 and histone deacetylase inhibitors cooperate to enhance NB4 cell differentiation and E-cadherin re-expression by chromatin remodelling.
Savickiene J; Treigyte G; Jazdauskaite A; Borutinskaite VV; Navakauskiene R
Cell Biol Int; 2012 Nov; 36(11):1067-78. PubMed ID: 22845560
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic changes by zebularine leading to enhanced differentiation of human promyelocytic leukemia NB4 and KG1 cells.
Savickiene J; Treigyte G; Jonusiene V; Bruzaite R; Borutinskaite VV; Navakauskiene R
Mol Cell Biochem; 2012 Jan; 359(1-2):245-61. PubMed ID: 21842375
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic and molecular mechanisms underlying the antileukemic activity of the histone deacetylase inhibitor belinostat in human acute promyelocytic leukemia cells.
Savickiene J; Treigyte G; Valiuliene G; Stirblyte I; Navakauskiene R
Anticancer Drugs; 2014 Sep; 25(8):938-49. PubMed ID: 24800886
[TBL] [Abstract][Full Text] [Related]
5. C/EBPα and PU.1 are involved in distinct differentiation responses of acute promyelocytic leukemia HL-60 and NB4 cells via chromatin remodeling.
Savickiene J; Treigyte G; Vistartaite G; Tunaitis V; Magnusson KE; Navakauskiene R
Differentiation; 2011 Jan; 81(1):57-67. PubMed ID: 20864248
[TBL] [Abstract][Full Text] [Related]
6. Response of retinoic acid-resistant KG1 cells to combination of retinoic acid with diverse histone deacetylase inhibitors.
Savickiene J; Treigyte G; Magnusson KE; Navakauskiene R
Ann N Y Acad Sci; 2009 Aug; 1171():321-33. PubMed ID: 19723072
[TBL] [Abstract][Full Text] [Related]
7. Anti-leukemic effects of HDACi Belinostat and HMTi 3-Deazaneplanocin A on human acute promyelocytic leukemia cells.
Valiulienė G; Stirblytė I; Jasnauskaitė M; Borutinskaitė V; Navakauskienė R
Eur J Pharmacol; 2017 Mar; 799():143-153. PubMed ID: 28192098
[TBL] [Abstract][Full Text] [Related]
8. Effects of histone deacetylase inhibitors, sodium phenyl butyrate and vitamin B3, in combination with retinoic acid on granulocytic differentiation of human promyelocytic leukemia HL-60 cells.
Merzvinskyte R; Treigyte G; Savickiene J; Magnusson KE; Navakauskiene R
Ann N Y Acad Sci; 2006 Dec; 1091():356-67. PubMed ID: 17341628
[TBL] [Abstract][Full Text] [Related]
9. Zebularine inhibits human acute myeloid leukemia cell growth in vitro in association with p15INK4B demethylation and reexpression.
Scott SA; Lakshimikuttysamma A; Sheridan DP; Sanche SE; Geyer CR; DeCoteau JF
Exp Hematol; 2007 Feb; 35(2):263-73. PubMed ID: 17258075
[TBL] [Abstract][Full Text] [Related]
10. Belinostat, a potent HDACi, exerts antileukaemic effect in human acute promyelocytic leukaemia cells via chromatin remodelling.
Valiuliene G; Stirblyte I; Cicenaite D; Kaupinis A; Valius M; Navakauskiene R
J Cell Mol Med; 2015 Jul; 19(7):1742-55. PubMed ID: 25864732
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic changes during hematopoietic cell granulocytic differentiation--comparative analysis of primary CD34+ cells, KG1 myeloid cells and mature neutrophils.
Navakauskienė R; Borutinskaitė VV; Treigytė G; Savickienė J; Matuzevičius D; Navakauskas D; Magnusson KE
BMC Cell Biol; 2014 Jan; 15():4. PubMed ID: 24443786
[TBL] [Abstract][Full Text] [Related]
12. Histone Acetyltransferase p300/CREB-binding Protein-associated Factor (PCAF) Is Required for All-
Sunami Y; Araki M; Kan S; Ito A; Hironaka Y; Imai M; Morishita S; Ohsaka A; Komatsu N
J Biol Chem; 2017 Feb; 292(7):2815-2829. PubMed ID: 28053092
[TBL] [Abstract][Full Text] [Related]
13. The epigenetic treatment remodel genome-wide histone H4 hyper-acetylation patterns and affect signaling pathways in acute promyelocytic leukemia cells.
Valiulienė G; Vitkevičienė A; Navakauskienė R
Eur J Pharmacol; 2020 Dec; 889():173641. PubMed ID: 33045196
[TBL] [Abstract][Full Text] [Related]
14. Functional diversity of DNA methyltransferase inhibitors in human cancer cell lines.
Stresemann C; Brueckner B; Musch T; Stopper H; Lyko F
Cancer Res; 2006 Mar; 66(5):2794-800. PubMed ID: 16510601
[TBL] [Abstract][Full Text] [Related]
15. The novel histone deacetylase inhibitor BML-210 exerts growth inhibitory, proapoptotic and differentiation stimulating effects on the human leukemia cell lines.
Savickiene J; Borutinskaite VV; Treigyte G; Magnusson KE; Navakauskiene R
Eur J Pharmacol; 2006 Nov; 549(1-3):9-18. PubMed ID: 16978604
[TBL] [Abstract][Full Text] [Related]
16. GW5074 and PP2 kinase inhibitors implicate nontraditional c-Raf and Lyn function as drivers of retinoic acid-induced maturation.
Jensen HA; Bunaciu RP; Varner JD; Yen A
Cell Signal; 2015 Aug; 27(8):1666-75. PubMed ID: 25817574
[TBL] [Abstract][Full Text] [Related]
17. Effects of a novel DNA methyltransferase inhibitor zebularine on human breast cancer cells.
Billam M; Sobolewski MD; Davidson NE
Breast Cancer Res Treat; 2010 Apr; 120(3):581-92. PubMed ID: 19459041
[TBL] [Abstract][Full Text] [Related]
18. Anti-tumoral effect of the non-nucleoside DNMT inhibitor RG108 in human prostate cancer cells.
Graça I; Sousa EJ; Baptista T; Almeida M; Ramalho-Carvalho J; Palmeira C; Henrique R; Jerónimo C
Curr Pharm Des; 2014; 20(11):1803-11. PubMed ID: 23888969
[TBL] [Abstract][Full Text] [Related]
19. Antagonism between granulocytic maturation and deacetylase inhibitor-induced apoptosis in acute promyelocytic leukaemia cells.
Hennig D; Müller S; Wichmann C; Drube S; Pietschmann K; Pelzl L; Grez M; Bug G; Heinzel T; Krämer OH
Br J Cancer; 2015 Jan; 112(2):329-37. PubMed ID: 25514379
[TBL] [Abstract][Full Text] [Related]
20. Enhanced growth inhibition by combined DNA methylation/HDAC inhibitors in lung tumor cells with silenced CDKN2A.
Chen M; Voeller D; Marquez VE; Kaye FJ; Steeg PS; Giaccone G; Zajac-Kaye M
Int J Oncol; 2010 Oct; 37(4):963-71. PubMed ID: 20811718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]